Mycobacterium other than tuberculosis (MOTT) infection: An emerging disease in infliximab-treated patients

2007 ◽  
Vol 55 (6) ◽  
pp. 484-487 ◽  
Author(s):  
Edsel Maurice T. Salvana ◽  
Gregory S. Cooper ◽  
Robert A. Salata
2020 ◽  
Vol 20 ◽  
Author(s):  
Saiyad Bastaminejad ◽  
Salar Bakhtiyari

: COVID-19 is an emerging disease that is a major threat to the global community. The main challenge in this disease is the lack of proper or proven medication. The drugs used to treat this disease are only for symptomatic treatment. Studies of other coronaviruses, such as SARS and MERS, suggest that quercetin has sufficient potential to treat COVID-19. Previous studies have shown that quercetin reduces the entry of the virus into the cell by blocking the ACE2 receptor, as well as reducing the level of interleukin-6 in SARS and MERS patients. Therefore, the aim of this review was to scrutinize the potential of quercetin as a drug in the treatment of COVID-19 from a molecular perspective.


2021 ◽  
Author(s):  
Paul L. Chrétien ◽  
Cindy E. Morris ◽  
Magali Duffaud ◽  
Christel Leyronas
Keyword(s):  

ACS Nano ◽  
2021 ◽  
Author(s):  
Tahir Farooq ◽  
Muhammad Adeel ◽  
Zifu He ◽  
Muhammad Umar ◽  
Noman Shakoor ◽  
...  

2020 ◽  
Vol 101 ◽  
pp. 475-476
Author(s):  
B. Sumathi ◽  
B. Veeregowda ◽  
S. Byregowda ◽  
D. Rathnamma ◽  
S. Rajeswari ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Marion Grimaud ◽  
Julie Starck ◽  
Michael Levy ◽  
Clémence Marais ◽  
Judith Chareyre ◽  
...  

2013 ◽  
Vol 24 (3) ◽  
pp. 321-331 ◽  
Author(s):  
Richa Sood ◽  
D. Hemadri ◽  
S. Bhatia

2012 ◽  
Vol 32 (10) ◽  
pp. S80-S81 ◽  
Author(s):  
D.G.M. Sutton ◽  
L.J. Morrison ◽  
P.J. Pollock ◽  
C. Hahn ◽  
P.E. Johnston ◽  
...  

2011 ◽  
Vol 1 (3) ◽  
pp. 177-180 ◽  
Author(s):  
B Akhtardanesh ◽  
R Ghanbarpour ◽  
H Babaei ◽  
M Nazeri

Sign in / Sign up

Export Citation Format

Share Document